Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

196

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Atrial Fibrillation RecurrentCatheter Ablation

Interventions

DRUG

Dapagliflozin 10 mg [Farxiga]

Dapagliflozin 10 mg \[Farxiga\] for 3 months after catheter ablation of atrial fibrillation

Trial Locations (1)

Kaoshiung Chang Gung Memorial, Kaohsiung City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER